Immunoglobulin therapy - Bone marrow and peripheral blood stem cell

Essential information

Obligatory

Must not donate if:

Immunosuppressed.

Donors with recovered immunodeficiency:

Refer to a Designated Clinical Support Officer.

Discretionary

1. If the intravenous or subcutaneous human immunoglobulin was given before 1980, accept.
2. Routine ante- and post-natal use of anti-D immunoglobulin, accept.
3. If single dose prophylactic immunoglobulin has been given, accept.

Supporting information

See if relevant

• Hepatitis A
• Hepatitis B
• Rabies
• Tetanus immunisation

If treated with intravenous or subcutaneous human immunoglobulin:

• Transfusion

Additional information

Immunoglobulin used before 1980 is unlikely to be affected by vCJD.

Single dose immunoglobulin is unlikely to pose a significant risk for transmitting vCJD.

Regulatory information

This advice reflects advice from the MSBTO committee of the Department of Health.

Reason for change:

A link to 'Transfusion' has been added.

Version details:

BM-DSG Edition 203 Release 02 (11 December 2007)